tetano
Editor, Senior Moderator
Vaccine
. 2024 Dec 4:126579.
doi: 10.1016/j.vaccine.2024.126579. Online ahead of print. Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity
David Hodgson[SUP] 1 [/SUP], Stephany Sánchez-Ovando[SUP] 2 [/SUP], Louise Carolan[SUP] 3 [/SUP], Yi Liu[SUP] 2 [/SUP], A Jessica Hadiprodjo[SUP] 2 [/SUP], Annette Fox[SUP] 2 [/SUP], Sheena G Sullivan[SUP] 2 [/SUP], Adam J Kucharski[SUP] 4 [/SUP]
Affiliations
Epidemiological studies suggest that heterogeneity in influenza vaccine antibody response can be associated with specific host factors, including pre-vaccination immune status, age, gender, and vaccination history. However, the pattern of reported associations varies between studies. To better understand the underlying influences on antibody responses, we combined host factors and vaccine-induced in-host antibody kinetics from a cohort study conducted across multiple seasons with a unified analysis framework. We developed a flexible individual-level Bayesian model to estimate associations and interactions between host factors, including pre-vaccine HAI titre, age, sex, vaccination history and study setting, and vaccine-induced HAI titre antibody boosting and waning. We applied the model to derive population-level and individual effects of post-vaccine antibody kinetics for A(H1N1) and A(H3N2) influenza subtypes. We found that post-vaccine HAI titre dynamics were significantly influenced by pre-vaccination HAI titre and vaccination history and that lower pre-vaccination HAI titre results in longer durations of seroprotection (HAI titre equal to 1:40 or higher). We also observed that the effect of vaccination history on antibody boosting was stronger for egg-grown A(H1N1) vaccinating strains in individuals with higher pre-vaccination HAI titres, whereas this effect diminished for egg-grown A(H3N2) vaccinating strains. Consequently, for cell-grown A(H1N1), our inference finds that the expected duration of seroprotection post-vaccination was 171 (95 % Posterior Predictive Interval[PPI] 128-220) and 159 (95 % PPI 120-200) days longer for those who are infrequently vaccinated (<2 vaccines in last five years) compared to those who are frequently vaccinated (2 or more vaccines in the last five years) at pre-vaccination HAI titre values of 1:10 and 1:20 respectively. In addition, we found significant differences in the empirical distributions that describe the individual-level duration of seroprotection for A(H1N1) cell-grown strains. In future, studies that rely on serological endpoints should include the impact of pre-vaccine HAI titre and prior vaccination status on seropositivity and seroconversion estimates, as these can significantly influence an individual's post-vaccination antibody kinetics.
Keywords: Antibody kinetics; Mathematical modelling; Seasonal influenza; Vaccination.
. 2024 Dec 4:126579.
doi: 10.1016/j.vaccine.2024.126579. Online ahead of print. Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity
David Hodgson[SUP] 1 [/SUP], Stephany Sánchez-Ovando[SUP] 2 [/SUP], Louise Carolan[SUP] 3 [/SUP], Yi Liu[SUP] 2 [/SUP], A Jessica Hadiprodjo[SUP] 2 [/SUP], Annette Fox[SUP] 2 [/SUP], Sheena G Sullivan[SUP] 2 [/SUP], Adam J Kucharski[SUP] 4 [/SUP]
Affiliations
- PMID: 39638659
- DOI: 10.1016/j.vaccine.2024.126579
Epidemiological studies suggest that heterogeneity in influenza vaccine antibody response can be associated with specific host factors, including pre-vaccination immune status, age, gender, and vaccination history. However, the pattern of reported associations varies between studies. To better understand the underlying influences on antibody responses, we combined host factors and vaccine-induced in-host antibody kinetics from a cohort study conducted across multiple seasons with a unified analysis framework. We developed a flexible individual-level Bayesian model to estimate associations and interactions between host factors, including pre-vaccine HAI titre, age, sex, vaccination history and study setting, and vaccine-induced HAI titre antibody boosting and waning. We applied the model to derive population-level and individual effects of post-vaccine antibody kinetics for A(H1N1) and A(H3N2) influenza subtypes. We found that post-vaccine HAI titre dynamics were significantly influenced by pre-vaccination HAI titre and vaccination history and that lower pre-vaccination HAI titre results in longer durations of seroprotection (HAI titre equal to 1:40 or higher). We also observed that the effect of vaccination history on antibody boosting was stronger for egg-grown A(H1N1) vaccinating strains in individuals with higher pre-vaccination HAI titres, whereas this effect diminished for egg-grown A(H3N2) vaccinating strains. Consequently, for cell-grown A(H1N1), our inference finds that the expected duration of seroprotection post-vaccination was 171 (95 % Posterior Predictive Interval[PPI] 128-220) and 159 (95 % PPI 120-200) days longer for those who are infrequently vaccinated (<2 vaccines in last five years) compared to those who are frequently vaccinated (2 or more vaccines in the last five years) at pre-vaccination HAI titre values of 1:10 and 1:20 respectively. In addition, we found significant differences in the empirical distributions that describe the individual-level duration of seroprotection for A(H1N1) cell-grown strains. In future, studies that rely on serological endpoints should include the impact of pre-vaccine HAI titre and prior vaccination status on seropositivity and seroconversion estimates, as these can significantly influence an individual's post-vaccination antibody kinetics.
Keywords: Antibody kinetics; Mathematical modelling; Seasonal influenza; Vaccination.